September 25, 2013
Abiraterone acetate, a recently FDA-approved drug used to treat men with metastatic castration-resistant prostate cancer, significantly delays progression of pain and quality of life deterioration when taken in conjunction with prednisone.
September 19, 2013
Although cigarette use has declined among Americans, regulators face the challenge of communicating the dangers of new tobacco products along with reaching smokers in diverse communities who may not respond to traditional forms of anti-tobacco communication. To address these issues, the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) announced today that they are awarding a $19.4 million, five-year grant to fund a center at the University of North Carolina that will study issues related to tobacco prevention communication and regulation.
May 27, 2011
The sixth annual UNC Lineberger scientific retreat drew a record number of posters – 68 – for the poster session and competition – and close to 150 people for the talks and reception.
June 20, 2008
On June 20, Dr. Lisa Carey, medical director of the UNC Breast Center, gave a talk on “Everything You Always Wanted to Know about Breast Cancer But Were Afraid to Ask” in Dare County. This inaugural “Lunch & Learn” was held in the Cancer Resource Center of the Outer Banks Hospital with an at-capacity crowd of 40 people.
June 6, 2008
On Friday, June 6th, the UNC Specialty Clinic opened its doors to patients in Dare County and the surrounding areas. Dr. Thomas Shea, UNC Lineberger Comprehensive Cancer Center associate director of clinical outreach, and Jean Sellers, RN, oncology program manager traveled to Nag’s Head for the first day of clinic operations.
March 13, 2008
CHAPEL HILL, NC - A new collaboration between melanoma researchers in the School of Medicine at the University of North Carolina at Chapel Hill, the Renaissance Computing Institute (RENCI), and researchers from the departments of computer science, epidemiology, biostatistics, and statistics and operations research at UNC Chapel Hill aims to use image analysis techniques to aid doctors in the fight against melanoma, the most serious form of skin cancer.
January 24, 2008
CHAPEL HILL - Fred Eshelman, chief executive officer and founder of Wilmington-based PPD Inc., has pledged $9 million to support cancer research at the School of Pharmacy at the University of North Carolina at Chapel Hill.
January 22, 2008
CHAPEL HILL - The University of North Carolina’s two medical schools and their cancer centers have signed a memorandum of understanding that creates a partnership to advance cancer research and bring leading-edge treatment to North Carolinians.
October 17, 2007
CHAPEL HILL – The governance committee of the University Cancer Research Fund has established first-year spending priorities for the state’s initial $25 million investment at the University of North Carolina at Chapel Hill.
October 16, 2007
Stephen Frye, PhD, former worldwide head of discovery medicinal chemistry at GlaxoSmithKline, will lead the new Center for Integrative Chemical Biology and Drug Discovery at the University of North Carolina at Chapel Hill.
